PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Propio offers The Property ISA, a tax-efficient, simple and affordable way to invest in properties. The company aims to become the UK’s largest property-based ISA by making the experience of investing as straightforward as online shopping. Propio is powered by a team of property and finance heavyweights who hand-select all the investments, helping the customers reduce risks and earn stable, tax-free returns, irrespective of market fluctuation. The company’s client base comprises 1000+ customers who have invested over £7.5m in it. According to TrustPilot, Propio is among the top 10 investment companies in the UK, delivering average returns of 6.5% to investors, despite Brexit and stock market turmoil. Moreover, the company has partnered with two UK finance and property firms and expects an investment deal flow of up to £100m by 2021-22.
days to go:
Expired
investment:
£357,660
Bippit is a wellbeing platform that provides employees with financial consultancy from a professional with zero cost to the employees themselves. The company asserts that COVID-19 has made financial consultancy services difficult to access for employees. Bippit aims to resolve this situation. It is available in mobile and desktop formats and integrates with an employees’ entire financial life through 'Open Banking'. Bippit argues that this helps staff members receive all the tools they need to learn, plan, and take action concerning their finances. It also helps companies save time and money, ensures that employees receive an impartial support system, and allows financial experts to get an extra revenue stream. The company will launch an Initial Public Offering (IPO) likely within 5 years if it moves beyond strategic acquisition.
days to go:
Expired
investment:
£73,000
Patch is a modern plant shop for contemporary plant people. It helps in finding the most suitable plants and delivering them to the door. The company has delivered over 2,50,000 plants to over 82,000 customers in Paris and London. Patch has witnessed solid growth at +124% vs last year, reaching £4.48m in revenue. The company has a 4.6-star rating on TrustPilot and, it has been featured in The Times, The Telegraph etc. The funds will be used to expand across Europe, eliminate the middle-man and expand into the B2B market.
days to go:
Expired
investment:
£2,412,150
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.
days to go:
Expired
investment:
£340,928
Spendology is a fintech company that licenses a digital-first SaaS-based travel money platform to retailers globally, addressing the demand for travel cash, which remains popular among Brits, with over £56 billion spent annually. Inspired by the inconvenience of traditional currency exchange services, the company's chairman, Don Clark, aims to revolutionize the industry, much like he did in a previous financial services venture that resulted in a significant sale. Spendology's innovative platform allows travel companies to offer online ordering and home delivery of travel cash, generating additional profits for these businesses and royalties for Spendology. Their platform is available to travel companies of all sizes worldwide, already operating in the UK and launching in the US, with plans to expand to 28 countries, serving a market worth $1 trillion.
days to go:
Expired
investment:
£354,053
Website: www.riskrewardlimited.com
Risk Reward Ltd is a global banking and financial services training, consultancy and recruitment specialist that operates from its offices in London and recently opened a second office in Miami to service its business in the Americas. The company specialises in risk and compliance training and recruitment, the fastest growing part of the sector.
The business is raising equity investment for the first time in its 13-year history, giving investors the first opportunity to become part of this successful and fast growing business.
Established in 2002, Risk Reward’s client list has evolved to incorporate the names of national and international banks, leading financial services companies and insurance firms spanning five continents. Clients include international training firms and specific banks including the British Bankers Association, GPS, MIS, Al Rajhi Bank, FBN, First Gulf Bank, HSBC, Lloyds Bank, Wells Fargo and many more prominent names.
Several growth-spurring developments are happening simultaneously to lead the company to offer 5% in its market-leading business to new investors:
* Exceptional growth in its training business; the company has developed its retail training business in London and Dubai, and has also developed its multi-lingual global training services
* Investment has been made in development of a new recruitment businesses which is now approved by a number of companies and has been followed by taking over the business of Buckley Alan, a 12 year old recruitment firm
* Recently opened a US office in Miami
* Developed a learning management system which is successfully installed in a major bank and links skills to training delivery
* Published two best-selling money laundering deterrence works and a major text on business mathematics
* Approved by 5 major institutes to offer their training products including the CISI, ICAEW and ACAMS
Sales vary month on month between £150,000 and £200,000, and recent unsolicited valuations have put the company’s worth between £7-12 million.
These valuations also took into account the level of investment written off during the year developing the learning management system, recruitment business and US office. Business growth is around 25% per annum in this fast growing sector.
The fast-moving business requires equity investment to fuel its growth as the company strives to develop its already-strong position as a technical leader in its space.
This pitch represents an opportunity to invest in a respected training and recruitment business with a wealth of prominent clients.
days to go:
Expired
investment:
£25,300
